CQDM

Consortium sur la découverte du médicament Navigation
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS

Post Archive by Year

Announcement of an investment of close to $8 million dollars in biopharmaceutical research in Québec

Monday June 8th, 2009News & Events

Announcement of a new funding from the Government of Canada

Monday February 23rd, 2009News & Events

LATEST NEWS

  • IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
    Monday March 18th, 2019
    Two antigens are targeted in combination with the DPX […]
  • Call for Applications for the Gordon Shore Prize – Internships for new graduates
    Thursday February 21st, 2019
    Created by CQDM, Diazon Pharmaceuticals, the Oncopole, […]
  • Philippe Walker appointed Member of the Scientific Advisory Board of CQDM
    Tuesday January 29th, 2019
    Montreal, January 29th, 2019. – CQDM is pleased to […]

About CQDM

  • Our Mission, Vision and Impact
  • Structure & Governance
  • Team
  • Members
  • Collaborators
  • Contact Us

Programs

  • SynergiQC
  • Quantum Leap
  • Mentorship
  • Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2019 // Web: Draxo Marketing

We use cookies and other tracking technologies to improve your browsing experience on our website. By browsing our website, you consent to our use of cookies and other tracking technologies. Accept